Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a).
about
Oxidized phospholipids and lipoprotein-associated phospholipase A2 as important determinants of Lp(a) functionality and pathophysiological roleTowards lipidomics of low-abundant species for exploring tumor heterogeneity guided by high-resolution mass spectrometry imagingPro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysisImaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directionsRelationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trialRhesus monkey (Macaca mulatta) lipoprotein(a) and apolipoprotein(a): high frequency of small size apolipoprotein(a) isoformsLipoprotein (a) upregulates ABCA1 in liver cells via scavenger receptor-B1 through its oxidized phospholipidsHeritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.Lipoprotein(A) with An Intact Lysine Binding Site Protects the Retina From an Age-Related Macular Degeneration Phenotype in Mice (An American Ophthalmological Society Thesis).Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a).Antisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humansPopulation and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population Study.Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?High Serum Immunoglobulin G and M Levels Predict Freedom From Adverse Cardiovascular Events in Hypertension: A Nested Case-Control Substudy of the Anglo-Scandinavian Cardiac Outcomes TrialLiberating Chiral Lipid Mediators, Inflammatory Enzymes, and LIPID MAPS from Biological Grease.Lipoprotein(a) as a therapeutic target in cardiovascular disease.Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans.Pathobiology of Lp(a) in calcific aortic valve disease.Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis.Structure, function, and genetics of lipoprotein (a).Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis.Significant differentiation in the apolipoprotein(a)/lipoprotein(a) trait between chimpanzees from Western and Central Africa.Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies.Emerging Therapeutic Options for Lowering of Lipoprotein(a): Implications for Prevention of Cardiovascular Disease.HDL-C, ABCA1-mediated cholesterol efflux, and lipoprotein(a): insights into a potential novel physiologic role of lipoprotein(a).Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects.LPA Gene, Ethnicity, and Cardiovascular Events.Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis.Lipoprotein(a) in clinical practice: New perspectives from basic and translational science.NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis.Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With LoLipoprotein(a) Induces Human Aortic Valve Interstitial Cell CalcificationLipoprotein(a) Levels in Patients With Abdominal Aortic Aneurysm
P2860
Q26747100-4653B53B-34A6-4F54-B782-2054A471A225Q28393497-9E50781F-7E70-4066-973A-4E84789CD85CQ33561072-11F8B61E-0DF6-4D57-B292-12DC422AA76DQ33831563-6DD4B3AD-9EBF-4C25-AFE5-010B6A2FFC7EQ34518372-9779535E-34B6-47C7-AEB3-BC1291B3AFACQ35276226-A5BA2F48-8427-4A46-99CA-42C3A268C344Q35602654-E3F41322-EEDE-460E-B7C3-D16B9DE98ECBQ35776641-F21EBDA3-C0C5-4D48-B8BC-7F19D44C54E8Q35789087-DCFD0B09-4817-4A55-9AB3-7D062C18A3C9Q36148940-D084DBF9-9DB4-4979-99E1-8A620651D63CQ36307282-0C99149F-7833-46D8-8A69-99D4A40BF256Q36617508-1B2CF599-DB0F-4A15-9C88-64ED3C96E2EDQ36731797-770509D5-5247-4453-907F-43ACEA0EC3B3Q36843336-AF275D3F-AAF7-4F90-843D-2D027E882513Q37149945-A88A23BA-3427-4E09-B4B9-79FD690BC676Q37421407-A108BD07-9DBF-49D8-B534-31B6E6CF107FQ38213476-4226489A-ED7F-4431-8D8B-0359DA8094EAQ38389141-0C20BA43-0F4F-42F1-808E-8164F97A3F14Q38620736-AFD51D99-0017-45DD-AD9D-D0A6ED76A331Q38701405-1AEE7096-0965-40E0-BCAB-FE55C4C6E1F0Q38807488-69F1CEAC-B243-4206-9232-6D8CE5361E4EQ38839978-10B1116C-B59E-4E13-A726-35CF6771ECCEQ38849823-903E93C3-24D8-4FB8-BF5F-1C521475FA93Q38966500-E0130FAC-1F8F-4B08-895B-AC36F5202D09Q38985774-7E910FD0-FE6F-4826-A2CF-AE2472418191Q42408461-A2F7BE02-09BD-4883-91B0-2B6A403CE676Q43188537-119011D8-6B07-48A3-91C1-80FE3726AEA1Q46076964-8D99B955-1119-4EEE-BF25-C65D01D3B139Q46229988-54F41098-239C-4F69-9C72-8527F17F6471Q46259874-F4E6C6F7-67C0-41E2-A18C-1E1C28455665Q47274864-305CCEBA-92CE-46E9-A34D-D7A51A6A47C5Q50081201-851E1792-3D1D-4446-B142-5BA35940D117Q50187728-2F2A46C1-A392-43EB-87C0-5CDC2747852CQ57150402-D21D814C-88CA-4E4E-824F-BFD5DC13B1EEQ58886358-51A6BC26-60A7-4136-AAC4-522B153C22BB
P2860
Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Determinants of binding of oxi ...... otein (a) and lipoprotein (a).
@en
Determinants of binding of oxidized phospholipids on apolipoprotein
@nl
type
label
Determinants of binding of oxi ...... otein (a) and lipoprotein (a).
@en
Determinants of binding of oxidized phospholipids on apolipoprotein
@nl
prefLabel
Determinants of binding of oxi ...... otein (a) and lipoprotein (a).
@en
Determinants of binding of oxidized phospholipids on apolipoprotein
@nl
P2093
P2860
P50
P356
P1476
Determinants of binding of oxi ...... otein (a) and lipoprotein (a).
@en
P2093
Marlys L Koschinsky
Matthias Schneider
Simone Green
Xiaohong Yang
P2860
P304
P356
10.1194/JLR.M040733
P50
P577
2013-07-04T00:00:00Z